Cue Biopharma Inc. (CUE)
0.79
0.04 (5.33%)
At close: Apr 02, 2025, 3:59 PM
0.78
-1.66%
After-hours: Apr 02, 2025, 06:56 PM EDT
Cue Biopharma Income Statement
Financials in USD. Fiscal year
is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
| Revenue | 9.29M | 5.49M | 1.25M | 14.94M | 3.15M | 3.46M | 1.14M | n/a | n/a | n/a |
| Cost of Revenue | n/a | 38.1M | 1.81M | -1.78M | 33.55M | 27.49M | 28.54M | 419.57K | 202.09K | 44.81K |
| Gross Profit | 9.29M | -32.61M | -560.83K | 16.72M | -30.39M | -24.03M | -27.4M | -419.57K | -202.09K | -44.81K |
| Operating Income | -41.5M | -52.15M | -53.22M | -43.71M | -45.04M | -36.77M | -38.7M | -23.23M | -7.66M | -1.93M |
| Interest Income | 1.62M | 2.66M | 928.24K | 45.9K | 463.91K | 419K | 376.01K | 35.00 | 52.00 | n/a |
| Pretax Income | -40.67M | -50.73M | -53.01M | -43.67M | -44.58M | -36.29M | -38.16M | -23.23M | -7.66M | -1.93M |
| Net Income | -40.67M | -50.73M | -52.8M | -44.16M | -44.78M | -36.7M | -38.98M | -23.23M | -7.66M | -1.93M |
| Selling & General & Admin | 14.59M | 16.68M | 16.17M | 17.31M | 14.65M | 12.74M | 11.3M | 4.33M | 1.97M | 425.08K |
| Research & Development | 36.3M | 40.8M | 38.58M | 41.35M | 33.55M | 27.49M | 28.54M | 18.9M | 5.69M | 1.5M |
| Other Expenses | n/a | -37.94M | n/a | n/a | n/a | 64K | 165.34K | n/a | n/a | n/a |
| Operating Expenses | 50.88M | 19.54M | 54.75M | 58.65M | 48.2M | 40.23M | 39.84M | 23.23M | 7.66M | 1.93M |
| Interest Expense | -796K | 1.25M | 713.82K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 50.79M | 57.64M | 54.75M | 58.65M | 48.2M | 40.23M | 39.84M | 23.23M | 7.66M | 1.93M |
| Income Tax | n/a | n/a | -214.43K | 495K | 206.25K | 412K | 825K | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 56.33M | 45.75M | 35.65M | 31.29M | 28.69M | 22.04M | 20.13M | 20.64M | 20.64M | 20.64M |
| Shares Outstanding (Diluted) | 56.33M | 45.75M | 35.65M | 31.29M | 28.69M | 22.04M | 20.13M | 20.64M | 20.64M | 20.64M |
| EPS (Basic) | -0.72 | -1.11 | -1.48 | -1.41 | -1.56 | -1.66 | -1.94 | -1.13 | -0.37 | -0.09 |
| EPS (Diluted) | -0.72 | -1.11 | -1.48 | -1.41 | -1.56 | -1.66 | -1.94 | -1.13 | -0.37 | -0.09 |
| EBITDA | -41.5M | -46.05M | -50.49M | -45.44M | -43.99M | -35.96M | -37.94M | -22.81M | -7.46M | -1.88M |
| EBIT | -41.47M | -49.49M | -52.3M | -43.67M | -45.04M | -36.77M | -38.7M | -23.23M | -7.66M | -1.93M |
| Depreciation & Amortization | n/a | 3.44M | 1.81M | -1.78M | 1.06M | 5.35M | 760.01K | 419.57K | 202.09K | 44.81K |